Iron oxide nanoparticles as a drug carrier reduce host immunosuppression for enhanced chemotherapy.
Ontology highlight
ABSTRACT: Chemotherapy is still regarded as the main modality for cancer treatment. However, it often suppresses the host immune system, resulting in limited therapeutic effects. It is desirable to design a novel chemotherapeutic agent to reduce the level of immunosuppression. Herein, we designed bovine serum albumin (BSA)-bioinspired iron oxide nanoparticles (IONPs) as a nanocarrier to load anticancer drug mitoxantrone (MTX) for enhanced chemotherapy of orthotopic breast cancer. The treatment with IONPs@BSA-MTX complexes increased CD3+CD4+ and CD3+CD8+ T lymphocytes more than free MTX. The complexes effectively restored the host immune system and exhibited a better anticancer efficacy than free MTX. It was worth noting that the BSA-inspired IONPs were a s
SUBMITTER: Zhou B
PROVIDER: S-EPMC9001247 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA